MadSci Network: Medicine
Query:

Re: Leukemia treatment: bone marrow stem cells vs peripheral blood stem cells

Date: Fri Jul 17 10:18:16 2009
Posted By: Dr. Ankur Shah, Doctor (MBBS), Medical Officer
Area of science: Medicine
ID: 1242741813.Me
Message:

Hematopoietic stem cell therapy is used widely for treatment of leukemia.
The traditional source of hematopoietic stem cells for use in
transplantation was bone marrow. The use of peripheral blood as a source of
stem cells has now replaced bone marrow for most transplants. 
The difference between the two sources can be brought out in the table
given below:

Cellular Characteristics       Bone Marrow       Peripheral Blood
Stem cell content               Adequate            Good
Progenitor cell content         Adequate            Good
T-Cell content                     Low              High

Bone Marrow harvesting under general anesthesia is limited by procedural
risks (largely related to general or spinal anesthesia), which
significantly increase with the donor's age and comorbid conditions.
Peripheral Blood Stem Cell harvesting, on the other hand, can be performed
safely on donors ranging from 1 year to the eighth decade. The principal
limitation of the procedure is the need for venous access. 

Engraftment with peripheral blood is faster as compared to bone marrow, but
again on the flip side, the risk of chronic graft vs host disease in
patients has been found to be higher with peripheral blood stem cell
transplantation.
However, various studies have shown no difference between stem cell source
and relapse rates or disease free survival. A difference in relapse rates,
in favour of peripheral blood stem cells, does however emerge when patients
are classified as per stage of leukemia. It is said that Peripheral blood
stem cell transplantation is likely to overtake bone marrow, owing to the
longer disease free survival rate in advanced stage cancer. Also added is
the fact that it is easier to harvest specific cell types by immunogenic
stimulation from peripheral blood than bone marrow make PBSC a more
attractive option..

References:
1. Hematopoietic Stem Cell Transplantation, http://emedicine.medscape.com
2. Peripheral blood stem cell versus bone marrow allotransplantation: does
the source of hematopoietic stem cells matter? Korbling and Anderson,
Blood, 15 November 2001, Vol. 98, No. 10, pp. 2900-2908



Current Queue | Current Queue for Medicine | Medicine archives

Try the links in the MadSci Library for more information on Medicine.



MadSci Home | Information | Search | Random Knowledge Generator | MadSci Archives | Mad Library | MAD Labs | MAD FAQs | Ask a ? | Join Us! | Help Support MadSci


MadSci Network, webadmin@madsci.org
© 1995-2006. All rights reserved.